Finasteride
None
Technical catalog description
Finasteride is a 5α-reductase inhibitor that prevents the conversion of testosterone to dihydrotestosterone (DHT). It’s primarily used to prevent hair loss from testosterone and other compounds that convert to DHT.
While effective for testosterone-induced hair loss, finasteride is INEFFECTIVE and may actually WORSEN hair loss when used with DHT derivatives like masteron, winstrol, or anavar, or with 19-nor compounds like trenbolone and nandrolone.
Read next
Finasteride only solves one problem: conversion of Testosterone to DHT through 5AR. If the cycle is mostly testosterone, or testosterone plus other compounds that do not dominate the hair-loss picture, finasteride can materially reduce scalp DHT exposure. If the cycle is built around DHT derivatives such as Masteron, Winstrol, or Anavar, the mechanism does not help because those compounds are already downstream of 5AR.
The Nandrolone exception matters. Nandrolone converts to dihydronandrolone, which is weaker at androgen-sensitive tissues than nandrolone itself. Blocking that conversion with finasteride can leave the stronger parent hormone in play at the follicle. Users sometimes report worse hair outcomes on nandrolone when they add finasteride. It is not paradoxical once the pathway is understood.
Reduced libido, erectile issues, and blunted mood in some users
Can worsen hair outcomes when used with the wrong compounds
Sexual function
hair-shedding trend rather than panic over day-to-day variation
Cycles built around DHT derivatives or 19-nor compounds where it will not help
Users highly sensitive to sexual or mood side effects
Finasteride is chosen because it is the least aggressive way to reduce DHT in Testosterone-based setups. It is inexpensive, familiar, and easier to discontinue than Dutasteride. For users who already know that testosterone is the main driver of shedding, it is the logical first intervention before escalating to broader suppression.
DHT reduction happens quickly, but cosmetic hair changes move slowly. Reduced shedding may be noticeable within weeks. Any real change in density or hairline stability is judged over months, not days. That slow feedback loop is why impatient users often misread whether it is helping.
Source reference information
Product reference · male pattern hair loss. Diagnosis and product context matter; a labeled reference does not become a personal prescription. References remain separate from quantities entered in a plan.
Label regimen: 1 mg/day total. Once daily. Labeled oral finasteride reference for male pattern hair loss. Population: Men with androgenetic alopecia. Route: oral; formulation: Finasteride 1 mg tablet. Not a reference for every cause of hair loss or for women/children. Label describes sexual adverse effects and PSA interpretation precautions; reference is not a risk score. Source: Finasteride 1 mg prescribing information.
The main mistake is treating finasteride as general hair protection for all androgens. Another is assuming that a small amount rules out side effects. This profile does not validate an amount below which those effects are absent.
Compared with Dutasteride, finasteride is narrower, easier to reverse, and usually the better first step. Compared with simply lowering the androgen that is causing the shedding, it is a compromise tool rather than a perfect fix.